
American Society of Addiction Medicine Level 1 - Opioid and Medication Assist Treatment
WORD with Dr. Michael David Clay di Dr. Michael David Clay
S1 · E8
10 mag 2020
44:51
Note sull'episodio
As the clinical presentation would include either overt INTOXIFICATION and/or RISK FOR WITHDRAWAL, there is also a corresponding risk for RELAPSE and ONGOING USE.
Implicitly this risk thus reduces the efficacy of Level 1 Outpatient Care absent Medication Assist Treatments, such as that of combining psychological counseling with prescribed Buprenorphine and Naloxone.
With an immediate reduction in the use of opioids, the body is given much needed time to physically, cognitive, and psycho-socially recover.
Contact:
Michael David Clay, D. Min., M.A.
Licensed Professional Clinical Counselor
thewordhouse@frontier.com.
Parole chiave
recovery
level 1 medication assist treatment
asam criterion
opioid treatment
buprenorphine naloxone
success